Elephant seals naturally experience prolonged periods of absolute food and water deprivation (fasting).
Introduction 1
Spontaneous long term fasting is an integral part of the life history of phocid seals (Castellini and Rea, 2 1992) . The northern elephant seal (Mirounga angustirostris) annually undergoes natural periods of 3 prolonged fasting, while breeding, molting and weaning (Le Boeuf et al., 1972) . Prolonged fasting in 4 elephant seals is associated with a series of physiological changes that result in the activation of the 5 hypothalamic-pituitary-adrenal axis (HPA) (Ortiz et al., 2003a; Ortiz et al., 2003b; Ortiz et al., 2001) and 6 the renin angiotensin system (RAS) (Ortiz et al., 2006; Ortiz et al., 2000) , as well as in the onset of insulin 7 resistant-like conditions (Fowler et al., 2008; Viscarra et al., 2011a; Viscarra et al., 2011b; Viscarra et al., 8 2012) . 9 10 Prolonged fasting, insulin resistance, and chronic HPA and RAS activation, induce oxidative stress by 11 activating NADPH oxidase (Nox) proteins, increasing mitochondrial oxidant generation and depleting 12 antioxidants in humans, rats and mice (Ceriello and Motz, 2004; Costantini et al., 2011; Evans et al., 13 2003; Romero and Reckelhoff, 1999; Sorensen et al., 2006; Souza Rocha et al., 2008; Sowers, 2002; 14 Szkudelski et al., 2004) . In the northern elephant seal, prolonged fasting increases Nox4 and xanthine 15 oxidase (XO) without increasing oxidative damage or inflammation (Soñanez-Organis et al., 2012; 16 Vázquez-Medina et al., 2010) . Systemic and muscle markers of oxidative damage (F 2 -isoprostanes, 17 nitrotyrosine, C-reactive protein, TNF-α, 4-hydroxynonenal, protein carbonyls) remain unchanged after 18 two months of absolute fasting in seal pups (Vázquez-Medina et al., 2010) . Fasting-related increases in 19 the activity and protein expression of several antioxidant enzymes and glutathione (GSH) levels 20 (Vázquez-Medina et al., 2010; Vázquez-Medina et al., 2011b) , as well as increased purine recycling 21 (Soñanez-Organis et al., 2012) , likely contribute to the prevention of oxidative damage in elephant seals. 22
23
How the antioxidant system is up-regulated in response to prolonged fasting in elephant seals remains 24 elusive. The nuclear factor erythroid 2-related factor 2 (Nrf2) is a central regulator of the adaptive 25 response to oxidative stress (Jaiswal, 2004) . Nrf2 induces the transcription of genes involved in 26 antioxidant defense through its binding to the electrophilic responsive element (EpRE) (Itoh et al., 1997) . 27
Nrf2 is a member of the basic leucine-zipper NF-E2 family that is bound to its repressor protein Keap1 28 under unaltered conditions (Itoh et al., 1995) . Binding of Nrf2 to Keap1 targets its ubiquitin conjugation 29 and consequent proteosomal degradation (Itoh et al., 1997) . Increases in intracellular oxidant 30 generation modify Cys273 and Cys288 residues in Keap1, inhibiting Nrf2 ubiquitination and promoting 31 its nuclear translocation and binding to the EpRE (Bloom and Jaiswal, 2003; Kobayashi et al., 2004; 32 into pre-chilled EDTA-treated collection tubes containing 10 µL mL -1 protease inhibitor cocktail (PIC) and 75 0.005% BHT (Sigma, St. Lous MO, USA), and centrifuged on site before plasma was aliquoted into 76 separate cryovials. Muscle biopsies (20-30 mg) were collected from a small region in the flank of the 77 animal near the hind flipper as previously described (Vázquez-Medina et al., 2010; Vázquez-Medina et 78 al., 2011b) . Tissue samples were rinsed with ice-cold sterile saline solution and placed in cryogenic vials. 79
Plasma and tissue samples were frozen by immersion in liquid nitrogen immediately after collection and 80 stored at -80°C until analyzed. 81
82

Angiotensin II infusions 83
Fifteen additional seal pups (7 males, 8 females, 1-3 weeks postweaned) were randomly assigned to 84 three experimental groups (n = 5 per group): 1) control, 2) Ang II (3.6 μg kg Sankyo, Tokyo, Japan) were infused at a rate of 1 mL min -1 through the extradural spinal vein. Blood 88 samples were collected at 0, 10, 30, 60 and 120 minutes post-infusion. Muscle biopsies were collected 89 before and 1 h after the intravenous infusion. Blood and tissue samples were processed as described in 90 the sample collection section. 91
92
Plasma analyses 93
Plasma Ang II was extracted using methanol and measured using a commercial RIA kit (Phoenix 94 Pharmaceuticals Inc, Burlingame, CA, USA) previously validated for the northern elephant seal (Zenteno-95 Savin and Castellini, 1998) . Plasma aldosterone was also measured using a commercially available RIA kit 96 6 (Siemens Medical Solutions, Los Angeles, CA, USA) that has been validated for elephant seals (Ortiz et 97 al., 2000) . Plasma TGF-1 was measured using a Mouse/Rat/Porcine/Canine Quantikine® immunoassay 98 kit following manufacturer's instructions (R&D Systems, Minneapolis, MN, USA). 99
100
Western blot 101
Frozen tissue samples were homogenized 1:20 (w/v) in RIPA (50 mM Tris-HCl, 150 mM NaCl, 1% NP-40, 102 0.5% Sodium deoxycholate, 0.1% SDS) buffer supplemented with a cocktail of protease and phosphatase 103 inhibitors (Pierce) (crude extracts). Nuclear protein fractions were prepared from frozen tissue samples 104 using the Pierce NE-PER nuclear extraction kit supplemented with protease and phosphatase inhibitors. 105
Total protein content in crude extracts and nuclear fractions was measured using the Bio-Rad Bradford 106 protein assay (Bio-Rad Laboratories, Hercules, CA, USA). Twenty μg of crude extract or 10 ug of nuclear 107 protein were mixed with Laemmli sample buffer, boiled and resolved in 4-12% Tris-glycine acrylamide 108 gels under denaturing conditions. Proteins were electroblotted onto nitrocellulose membranes using a 109
Bio-Rad Trans Blot Turbo transfer cell. Membranes were blocked with 3% bovine serum albumin 1h at 110 room temperature and incubated overnight with antibodies against Smad (Cell Signaling Technology, 111
Boston, MA, USA; Smad2: cat # 5339; Phospho-Smad2 Ser465/467, cat # 3104) and Nrf2 (Santa Cruz 112 Biotechnology, Santa Cruz, CA, USA, cat # 8882). Nox4 protein expression was detected using 113 monoclonal commercial antibodies (Epitomics Inc., Burlington, CA, USA, cat # 3174-1) raised against a 114 peptide sequence within the NADPH binding domain of Nox4 that is unique among NADPH oxidases, but 115 is conserved between mammalian protein sequences (Lee et al., 2010) . Membranes were incubated 116 with HRP-conjugated secondary antibodies (Pierce) and developed using Super Signal West Pico ECL 117 substrate (Pierce). Blots were visualized using a Kodak Image Station 440 (Kodak, Rochester, NY, USA) 118 and quantified using Kodak 1D 3.6 Image Analysis Software. Percent change from week 1 was calculated 119 after band densities were normalized using actin (crude extracts) or TATA binding protein (nuclear 120 fractions). 121
122
Nrf2 transcription factor activity 123
Binding of activated Nrf2 to the EpRE was measured in nuclear extracts using a TransAM® Nrf2 mixed and subjected to the following conditions: 94°C for 3 min for one cycle; 40 cycles of 94°C for 30 s, 142 55°C for 40 s and 68°C for 2 min; and to an overextension step of 68°C for 7 min. PCR fragments of 230 143 (esNox4a), 1200 (esNox4b) and 550 bp (esNox4c) were obtained and cloned using the pGEM-T Easy 144
Vector System (Promega Corporation, Fitchburg, WI, USA). Sequences were identified as Nox4 by 145 comparing them with GenBank data using the Blast algorithm. A partial sequence of 1730 bp (esNox4) 146 that encodes for Nox4 was obtained by overlapping esNox4 -a, -b and -c sequences. 147 148 Nox4 and CuZnSOD mRNA expression was quantified using glyceraldehyde 3-phosphate dehydrogenase 149 (GAPDH) as internal standard (GeneBank accession No. NM_002046). Nox4 and GAPDH transcripts were 150 measured by quantitative reverse transcription PCR (qRT-PCR) using a 7500 Real-Time PCR system 151 (Applied Biosystems, Foster City, CA, USA) as described previously (Vázquez-Medina et al., 2011a) . 152
Positive and negative controls were included. Standard curves of Nox4 and GAPDH were run to 153 determine amplification efficiency, which was 99.8% for Nox4 and 99.5% for GAPDH, using dilutions 154 from 5×10 -4 to 5×10 -9 ng μl -1 of PCR fragments. Primer sequences used for qPCR (esealNox4Fw3 + 155 esealNox4Rv1 and CuZnSODF2 + CuZnRv2) are provided ( Plasma Ang II and TGF-β1 levels were measured to confirm that prolonged fasting activates RAS, and to 167 test if fasting also increases TGF-β. Plasma Ang II increased in a time dependent manner over the course 168 of the fast and was 500% higher at week 7 (257 ± 36 fmol mL ) and by 250% at week 7 (14 ± 6 ng mL -1 ) compared to week 1 (4 ± 1 ng mL -1 ) ( Figure 1B) . 171
Phosphorylation of Smad2 was measured to assess its association with increased circulating Ang II and 172 TGF-β1, potent activators of the Smad pathway. Smad2 phosphorylation in skeletal muscle was 58% 173 higher at week 5 and 120% higher at week 7 than at week 1 (Figure 2) . 174
Acutely infused Ang II activates Smad2 176
To confirm the effects of the fasting-induced increase in plasma Ang II on the Smad pathway, Smad2 177 phosphorylation was measured after acute intravenous infusion of Ang II, with and without an ARB. The 178 use of ARB helped confirm the contribution of Ang II to Smad phosphorylaton via AT1 activation. Plasma 179 aldosterone concentration increased from 398 ± 101 pg mL -1 at time 0, to a maximum of 770 ± 172 pg 180 mL -1 at 1 h, and decreased to 597 ± 53 pg mL -1 at 2h confirming the effectiveness of the Ang II infusion. 181
The increase in circulating aldosterone in response to acutely infused Ang II was completely inhibited by 182 the simultaneous infusion of the ARB ( Figure 3A) confirming the effectiveness of the ARB dosage to 183 block AT1. Smad2 phosphorylation increased by 84% in the Ang II infused animals ( Figure 3B) . 184 Phosphorylated Smad2 levels did not change in the Ang II + ARB group ( Figure 3B ), suggesting that Ang II 185 stimulates the Smad pathway by activating AT1. 186
187
Prolonged fasting increases Nox4 expression 188
Nox4 was cloned and sequenced, and its expression was measured, at mRNA and protein levels, to test 189 whether prolonged fasting, along with increasing Ang II and TGF-β, and activating Smad, increases Nox4. week 7 than at week 1 ( Figure 6A ). Nrf2 transcriptional activity increased 41% at week 5 and 76% at 207 week 7 compared to week 1 ( Figure 6B ). The mRNA levels of CuZnSOD, an antioxidant gene regulated by 208
Nrf2, also increased with fasting and were 174% higher at week 5 and 450% higher at week 7 than at 209 week 1. Taken together, these results suggest that prolonged fasting stimulates the antioxidant system 210 of the elephant seal by activating Nrf2 and that Nrf2 activation is likely mediated by increases in 211 systemic RAS and Nox4 expression. activating Nrf2 (Brigelius-Flohé and Flohé, 2011; Kobayashi and Yamamoto, 2005) . Intracellular oxidants 231 modify Nrf2, leading to its dissociation from Keap1 and its subsequent translocation into the nucleus 232
where it binds to the EpRE (Kobayashi et al., 2006; Zhang and Hannink, 2003) . Nox4 is constitutively 233 active (Helmcke et al., 2009; Martyn et al., 2006; Serrander et al., 2007) and is uniquely localized to 234 several intracellular membranes (Anilkumar et al., 2008; Block et al., 2009; Helmcke et al., 2009; Sun et 235 al., 2011) . Endogenous, low levels of H 2 O 2 derived from Nox4 have been recently suggested to control 236 Nrf2 activity in endothelial cells and cardiomyocytes in vivo (Brewer et al., 2011; Schröder et al., 2012) ; 237 thus, increases in Nox4 may activate Nrf2, which up-regulates the expression of antioxidant enzymes 238 during prolonged fasting in seals, as previously reported (Vázquez-Medina et al., 2010; Vázquez-Medina 239 et al., 2011b) . 240 241 TGF-β is a potent inducer of Nox4 expression via the Smad signaling pathway (Cucoranu et al., 2005; Liu 242 et al., 2010; Sturrock et al., 2006; Sturrock et al., 2007) . Ang II signaling downstream of AT1 can also 243 control Nox4 expression in vivo and in vitro (Arozal et al., 2010; Block et al., 2008; Wingler et al., 2001) . 244
Although Ang II up-regulates TGF-β via AT1 activation (Rosenkranz, 2004) , it can also activate the Smad 245 pathway independently of TGF-β (Rodríguez-Vita et al., 2005; Ruiz-Ortega et al., 2007) . Acutely infused 246
Ang II increased, and ARB prevented, Smad phosphorylation, suggesting that AT1 activation may directly 247 increase Nox4 expression (Rodríguez-Vita et al., 2005) . After two months of absolute fasting, however, 248 when both circulating Ang II and TGF-β concentrations are increased, fasting-associated increases in 249
Smad phosphorylation and Nox4 expression may be a consequence of the synergistic effects of chronic 250 and progressive increases in circulating Ang II and TGF-β (Sorescu, 2006) . Furthermore, the observed 251 increases in TGF-β may itself be a consequence of increased Ang II (Rosenkranz, 2004 ). An alternative 252 explanation for the increased levels or Nox4 at the end of the fasting is the activation of Nrf2 since Nox4 253 contains consensus sequences for the EpRE in its promoter region and direct regulation of Nrf2 on Nox4 254 has been found in vitro during hyperoxia and laminar shear stress (Goettsch et al., 2011; Pendyala et al., 255 2011) . (Fowler et al., 2008; Viscarra et al., 2011a; Viscarra et al., 2011b) , 261 high rates of glucose auto-oxidation (Champagne et al., 2005; Champagne et al., 2012; Houser et al., 262 2012 ) and lipid oxidation (Viscarra et al., 2012) , RAS activation (Ortiz et al., 2006; Ortiz et al., 2001) and 263 chronic HPA stimulation (Ortiz et al., 2003a; Ortiz et al., 2001) . Increased antioxidant defenses at the end 264 of the fast are also consistent with an increase in number and duration of sleep apnea bouts that 265 normally last between 8 and 12 min and constitute 80% of the seals' time on land (Blackwell and Boeuf, 266 1993; Castellini et al., 1994) , along with increases in the time spent submerged in near-shore waters 267 (Thorson and Le Boeuf, 1994) . Furthermore, repetitive sleep apneas and voluntary submersions increase 268 nuclear accumulation of Nrf2 in the skeletal muscle of late-fasting elephant seal pups (Vázquez-Medina 269 et al., 2011c). Therefore, physiological adjustments associated with both prolonged fasting and breath-270 holding may stimulate Nrf2, ultimately preconditioning seal muscle to tolerate diving-induced 271 ischemia/reperfusion, which follows immediately upon departure from the rookery (after fasting) and 272 which has the potential to increase oxidant generation and oxidative stress (Elsner et al., 1998; Vázquez-273 Medina et al., 2012; Zenteno-Savín et al., 2002) . 274
275
In summary, results demonstrate that prolonged fasting activates Nrf2 and suggest that such activation 276 is mediated by increased expression of Nox4. Furthermore, results suggest that Ang II stimulates Smad 277 and thus, can potentially regulate Nox4 expression through AT1 activation. Finally, results suggest that 278 physiological adjustments associated with prolonged fasting upregulate the antioxidant system of the 279 elephant seal, conferring enhanced antioxidant protection to tolerate fasting-related oxidant production 280 and diving-induced ischemia/reperfusion (Figure 7 ). The present study describes, for the first time, a 281 potential mechanism for the regulation of the adaptive response to oxidative stress during food 282 deprivation in mammals. 
